A RANDOMIZED, LACEBO-CONTROLLED TRIAL OF THE DOPAMINE-BETA-HYDROXYLASE (DBH) INHIBITOR,

$1,019,847FY2009Department of DefenseDOD

Tuscaloosa Research And Education Advancement Corporation

Investigators